How aspirin was discovered Krishna Sudhir

4,000 years ago, the ancient Sumerians
made a surprising discovery.

If they scraped the bark
off a particular kind of tree

and ate it,

their pain disappeared.

Little did they know that why they’d found

was destined to influence
the future course of medicine.

What the Sumerians had discovered was
a precursor to the medicine known today

as aspirin.

Aspirin’s active ingredient is found
commonly in willow trees

and other wild plants,

which is how it came to infuse
the medical traditions

of Sumer,

ancient Egypt,

ancient Greece,

and other cultures.

Around 400 BC, Hippocrates, thought
of as the father of modern medicine,

first recommended chewing willow bark
for pain relief

and making willow leaf tea
to ease the pain of childbirth.

But it took over 2,000 years for us to
comprehensively investigate its potential.

In the mid-18th century,

an Englishman named Edward Stone
ran five years of experiments,

showing that willow bark crushed
into a powder and eaten

could cure a fever.

It took nearly another 70 years
for a German pharmacist, Johann Buchner,

to finally identify and purify
the substance that made all this possible,

a compound called salicin.

By then, doctors were routinely
using willow bark

and other salicin-rich plants,
like the herb meadowsweet,

to ease pain, fever, and inflammation.

But identifying the exact compound
suddenly opened up the possibility

of manipulating its form.

In 1853, a French chemist managed
to chemically synthesize the compound,

creating a substance called
acetylsalicylic acid.

Then in 1897, the pharmaceutical company
Bayer found a new method

and began marketing the compound
as a pain reliever called aspirin.

This was widely recognized as one of
the first synthetic pharmaceutical drugs.

Originally, aspirin was
just Bayer’s brand name:

A for acetyl,

and spir for meadowsweet,

whose botanical name is
Spiraea ulmaria.

Soon, aspirin became synonymous with
acetylsalicylic acid.

As its influence grew, aspirin was found
to ease not just pain,

but also many
inflammation-related problems,

like rheumatoid arthritis,

pericarditis, which enflames
the fluid-filled sack around the heart,

and Kawasaki disease,

where blood vessels become inflamed.

Yet, despite aspirin’s medical value,

at this point, scientists still didn’t
actually know how it worked.

In the 1960s and 70s, Swedish
and British scientists changed that.

They showed that the drug interrupts
the production of certain chemicals

called prostaglandins,

which control the transmission
of pain sensations and inflammation.

In 1982, that discovery won
the researchers a Nobel Prize in Medicine.

Over time, research has also uncovered
aspirin’s risks.

Overconsumption can cause bleeding
in the intestines and the brain.

It can also trigger Reye’s Syndrome,

a rare but often fatal illness
that affects the brain and liver

in children with an infection.

And in the late 20th century,

aspirin’s success had been overshadowed
by newer pain killers

with fewer side effects,

like acetaminophen and ibuprofen.

But in the 1980s, further discoveries
about aspirin’s benefits

revived interest in it.

In fact, the 1982 Nobel Prize winners
also demonstrated

that aspirin slows production
of thromboxanes,

chemicals that cause clumping
of platelets,

which in turn form blood clots.

A landmark clinical trial showed that
aspirin reduced heart attack risk by 44%

in participants who took the drug.

Today, we prescribe it to people
at risk of heart attack or stroke

because it cuts the likelihood of clots
forming in the arteries

that supply the heart and brain.

Even more intriguingly,

there’s a growing body of research
that suggests

aspirin reduces the risk of getting
and dying from cancer,

especially colorectal cancer.

This might be due to aspirin’s
anti-platelet effects.

By reducing platelet activity, aspirin may
decrease the levels of a certain protein

that helps cancer cells spread.

These discoveries have transformed aspirin
from a mere pain reliever

to a potentially life-saving treatment.

Today, we consume about 100 billion
aspirin tablets each year,

and researchers continue searching
for new applications.

Already, aspirin’s versatility
has transformed modern medicine,

which is astounding considering
its humble beginnings

in a scraping of willow bark.

4000 年前,古苏美尔人
有了惊人的发现。

如果他们
从一种特殊的树上刮下树皮

并吃掉它,

他们的痛苦就会消失。

他们几乎不知道他们发现

的原因注定会
影响未来的医学进程。

苏美尔人发现的是
今天被称为阿司匹林的药物的前身

阿司匹林的活性成分
常见于柳树

和其他野生植物中,

这就是它如何融入

苏美尔、

古埃及、

古希腊

和其他文化的医学传统。

公元前400年左右,被
认为是现代医学之父的希波克拉底

首先推荐咀嚼柳树
皮缓解疼痛,

并制作柳叶茶
来缓解分娩疼痛。

但我们花了 2000 多年的时间来
全面研究它的潜力。

18 世纪中叶

,英国人爱德华·斯通(Edward Stone)进行
了 5 年的实验,结果

表明将柳树皮
碾成粉末食用

可以治愈发烧。

德国药剂师约翰·布赫纳(Johann Buchner)又花了将近 70 年的时间,

才最终鉴定和纯化
出使这一切成为可能的物质,

一种叫做水杨苷的化合物。

那时,医生经常
使用柳树皮

和其他富含水杨素的植物,
如草本绣线菊,

来缓解疼痛、发烧和炎症。

但确定确切的化合物
突然打开

了操纵其形式的可能性。

1853 年,一位法国化学家成功
地化学合成了这种化合物,

创造了一种叫做
乙酰水杨酸的物质。

然后在 1897 年,拜耳制药公司
发现了一种新方法,

并开始将这种化合物
作为一种叫做阿司匹林的止痛药进行销售。

这被广泛认为是
最早的合成药物之一。

最初,阿司匹林
只是拜耳的品牌名称:

A 代表乙酰基

,spir 代表绣线菊,

其植物学名称是
绣线菊。

很快,阿司匹林就成为
乙酰水杨酸的代名词。

随着阿司匹林的影响越来越大,人们发现阿司匹林
不仅可以缓解疼痛,还可以缓解

许多
与炎症相关的问题,

例如类风湿性关节炎、

使心脏周围充满液体的袋子发炎的心包炎,以及使

血管发炎的川崎病。

然而,尽管阿司匹林具有医疗价值,但

在这一点上,科学家们实际上仍然不
知道它是如何起作用的。

在 1960 年代和 70 年代,瑞典
和英国科学家改变了这一点。

他们表明,这种药物会
中断某些称为前列腺素的化学物质的产生,这些化学物质

控制
疼痛感和炎症的传递。

1982 年,这一发现
为研究人员赢得了诺贝尔医学奖。

随着时间的推移,研究也发现了
阿司匹林的风险。

过度消费会
导致肠道和大脑出血。

它还可能引发雷氏综合症,这

是一种罕见但通常是致命的疾病
,会影响受

感染儿童的大脑和肝脏。

在 20 世纪后期,

阿司匹林的成功被

对乙酰氨基酚和布洛芬等副作用较少的新型止痛药所掩盖。

但在 1980 年代,
关于阿司匹林益处的进一步发现

重新引起了人们对它的兴趣。

事实上,1982 年诺贝尔奖获得者
还证明

,阿司匹林可以减缓
血栓素的产生,血栓素

是导致血小板聚集的化学物质

,进而形成血栓。

一项具有里程碑意义的临床试验表明,
阿司匹林可将服用该药的参与者的心脏病发作风险降低 44%

今天,我们将它开给
有心脏病或中风风险的人,

因为它可以减少在

供应心脏和大脑的动脉中形成凝块的可能性。

有趣的是,越来越多的研究
表明,

阿司匹林可以降低患
癌症和死于癌症的风险,

尤其是结直肠癌。

这可能是由于阿司匹林的
抗血小板作用。

通过降低血小板活性,阿司匹林可能会
降低某种

有助于癌细胞扩散的蛋白质的水平。

这些发现将阿司匹林
从单纯的止痛药

转变为可能挽救生命的治疗方法。

今天,我们每年消耗大约 1000 亿
片阿司匹林片剂

,研究人员还在继续
寻找新的应用。

阿司匹林的多功能性
已经改变了现代医学,

考虑到

在柳树皮上的卑微开端,这令人震惊。